The business is led by RCVS Specialists in Small Animal Orthopaedics, Professor John Innes and Ben Walton, alongside American veterinary orthopaedic specialist and investor, Dr Brian Beale.
Two more Specialists are due to join the senior team in May.
Building work is apparently well underway on the 8000ft2 premises in Abbots Park, Preston Brook, which will be equipped with CT, high-field MRI, and three operating theatres.
The centre, which is located near Junction 11 of the M56, will provide referral services to veterinary practices from the conurbations of the North of England and the surrounding English and Welsh counties.
Ben Walton said: “For me, it is an honour to team up with John and Brian who have unparalleled international reputations, and I’m eagerly anticipating the arrival of our two additional colleagues.
"For veterinary professionals and clients, we are concentrating on responsive and clear communication, high clinical standards, and fair pricing.
"And finally, for prospective employees, we’re determined to foster a positive and supportive culture where vets, nurses and support staff can grow, thrive and enjoy a career.”
Until the opening of the new centre, Movement Referrals offers a peripatetic orthopaedics referral service based out of third party veterinary practices in the North West of England and North Wales.
www.movementvets.co.uk
Photo: from left to right: Prof. John Innes, Ben Walton, Dr Brian Beale
VetSurgeon member Andrew Dobson of The Barn Equine and Large Animal Practice in Great Wakering, Essex has won the inaugural Petplan Equine Vet of the Year Award.
Owners and riders all over the UK were invited to send in nominations for this new people's award. A short list of three finalists was then drawn up and the winner selected by an independent panel consisting of Jo Whitaker, brand manager for Petplan Equine; Alison Bridge, editor-in-chief of Horse&Rider magazine; David Stickels, head of fundraising for the AHT, and David Dugdale, president of the British Equine Veterinary Association (BEVA).
Andrew was nominated by a number of his grateful clients and their glowing testimonials impressed the judges enough to give him the edge over his closest rivals for the title.
"This award is intended to recognise the amazing hard work and commitment of people within the equine veterinary profession and those who provide outstanding service to horse owners," explained Jo Whitaker. "We received some very strong nominations and all three finalists are clearly exceptional vets. Andrew Dobson was nominated by a number of his clients and they all stressed his professionalism and devotion to the horses in his care and how he regularly goes beyond the call of duty in making sure that both horses and owners are given the very best treatment."
Suzy Dorey was among the clients to nominate Andrew: "When I came across Andy I realised that he was an old fashioned type of vet and had the time and patience to deal with the horses and just as importantly the clients. I cannot recommend Andy highly enough and would like to see him given recognition of some sort for being a dependable, down-to-earth vet."
Andrew said: "I am absolutely stunned. I'm so honoured and amazed to of received the Petplan Equine Vet of the Year award. I really enjoy what I do and would like thank all my clients, Petplan Equine, the Animal Health Trust and Horse&Rider for their support."
Agria Pet Insurance has announced the launch of a new campaign to highlight the threat to animals from everyday poisons and toxins.
As part of its campaign, the company is encouraging vets and nurses to help clients keep their pets safe by sharing knowledge about specific toxins - increasing awareness of substances which can cause harm.
To support vets in advising clients, Agria has produced a poster designed for in-practice display (pictured right, click to enlarge), covering some of the main threats to cats and dogs that owners may come across in their everyday lives. Dangers include: ingestion of antifreeze and paracetamol by cats, certain human foods and rock salt by dogs.
International Cat Care, currently running the campaign ‘Keeping Cats Safe’ in conjunction with Agria, feels that many poisonings could be prevented if only owners knew the risks.
Claire Bessant, from the charity, said “Accidental poisonings are heartbreaking because they are so often preventable - owners just weren’t aware of the dangers. Even worse, sometimes people are trying to help their animals - such as when owners give paracetamol, unaware that it can be lethal for cats.
"We’re delighted that Agria is helping reduce the risk of poisoning with this veterinary campaign and we encourage vets to do their bit and display a poster." To order a copy of Agria’s poster – ‘Responsible Pet Ownership Month – taking extra care of your pet!’– to display in your practice, email the Agria vet team at admin.vet@agriapet.co.uk, or call them on 03330 30 83 90.
The joint submission points to evidence from recent surveys indicating a current workforce shortage of 11% in small animal practice and an overall deterioration in the ability of practices to hire suitably qualified staff.
Following the exit from the EU, existing shortages will likely worsen, whilst changes in trade could increase the demand for veterinary skills, producing a shortfall in the UK’s capacity to ensure animal health and welfare, food safety and public health.
Placing the veterinary profession on the Shortage Occupation List would reduce restrictions on recruiting veterinary surgeons from abroad, something the response says will become a necessity post Brexit.
Currently about half of vets registering each year in the UK are graduates from the EU. If there are no appropriate immigration measures in place when the UK leaves the EU, this EU contribution could decline, leaving a large gap in the veterinary workforce. Research among BVA members has indicated that since the EU referendum, about one fifth are reporting that recruitment has already become harder. Meanwhile, a study commissioned by the RCVS has shown that nearly a third of veterinary surgeons and veterinary nurses whose nationality is non-UK European are considering a move back home.
The BVA / RCVS response highlights that although the veterinary profession is relatively small, it performs a range of roles that are vital to the UK’s economy and maintaining standards in society. Agriculture and food production would suffer from a lack of veterinary input, potentially reducing its livestock outputs worth £12.7bn in 2016, whilst the equine industry and aquaculture would also struggle. The companion animal veterinary market, that has a turnover of £3 billion, could experience significant losses due to workforce shortages.
Veterinary surgeons from the EU make a particularly significant contribution to critical roles in public health with estimates suggesting that 95% of Official Veterinarians working in abattoirs are from overseas and the large majority of these are from the EU. Reducing the veterinary presence in slaughterhouses would increase the risk of food fraud, provide the potential for animal welfare breaches and remove a level of public health reassurance.
While the number of UK veterinary graduates has increased year-on-year from the established veterinary schools, with potentially more schools in the pipeline, it is unlikely that UK universities can meet this increased demand in the short timeframe required. BVA, RCVS and Defra recently launched the Veterinary Capability and Capacity Project (VCCP) to help ensure the veterinary sector can continue to play its role in society.
BVA Senior Vice President Gudrun Ravetz said: "Our members have been reporting problems with recruitment and retention of vets for several years and this situation will only worsen under Brexit unless appropriate measures are in place. Vets are vital to our society. Across the UK vets are needed to certify imports and exports, conduct cutting-edge research, prevent disease outbreaks, ensure food safety in abattoirs and achieve our world leading standards in animal welfare.
"We are setting out a very strong case to add the profession to the Shortage Occupation List now to help us manage the immediate shortfall in critical veterinary roles, while the UK negotiates a longer term immigration policy that must meet the UK’s veterinary workforce needs post-Brexit without creating disproportionate administrative burdens for veterinary businesses."
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The first of our recently published Brexit Principles is that ‘vital veterinary work continues to get done’. In order to ensure this is met we want the Government to recognise that there are significant current and potential shortages in the profession that can only be mitigated by putting it on the Shortage Occupation List so that animal health and welfare and public health is safeguarded.
"Our ideal outcome is that EU veterinary surgeons currently living and working in the UK are allowed to stay indefinitely and that, in terms of any post-Brexit immigration system, graduates of European schools accredited by the European Association of Establishments for Veterinary Education (EAEVE) are allowed to work here with the minimum of restrictions."
More information is available in BVA/RCVS’s full response to the Migration Advisory Committee’s Call for Evidence:www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Get_involved/Consultation_archive/Migration%20Advisory%20Committee%20BVA%20RCVS%20Submission%20FINAL.PDF
To enter the competition, click here and list the BRD risk factors you can see.
The competition closes on 8th February 2019, when ten gilet winners will be picked at random from those entries that contain the most risk factors.
After the competition ends, you will also be able to download the cartoon for use in your practice and with your farming clients.
Mr Wood pleaded guilty to three charges of making indecent images of children at Portsmouth Magistrate’s Court in December 2017. Following his conviction, Mr Wood was given a community sentence, fined and made subject to a sexual harm prevention order for five years.
Mr Wood’s application for restoration was based on the argument that he was professionally competent to be restored to the Register, that he had strong mitigation for his original conviction (for which he had demonstrated remorse), that he had a low chance of reoffending, had engaged proactively with the Probation Service and rehabilitative courses, and that had completed his community service.
In considering Mr Wood’s application, the Disciplinary Committee took into account a number of factors including Mr Wood’s acceptance of the Committee’s original findings, the seriousness of the original findings, protection of the public, the future welfare of animals in his care should he be restored, the length of time off the Register, his conduct since removal from the Register, efforts by Mr Wood to keep up-to-date with his continuing professional development (CPD), the impact of removal from the Register on Mr Wood and public support for his restoration.
However, on balance, the Committee decided that Mr Wood was not currently fit to be restored to the Register.
Ian Arundale, chairing the Committee and speaking on its behalf, said: "In essence, the Committee decided that the facts of the charge justifying removal from the Register and the underlying criminal behaviour were too serious for Mr Wood to be restored at this time. It concluded that because Mr Wood continued to be subject to a sexual harm prevention order, notification requirements for sexual offenders and because he remained on the Barring List by the Disclosure and Barring service until January 2023, he was not fit to be restored to the Register at this time.
"The Committee accepted that Mr Wood had made significant efforts to rehabilitate himself but it was not persuaded that he was fit to be restored to the Register because ancillary orders relating to the underlying criminal offences remained in force. The Committee noted that at the time those orders were made Mr Wood was described as having an addiction and although the Committee accepted that there was a low risk of future reoffending, it decided that because the orders were still in place for public protection reasons, Mr Wood was not fit to be restored to the Register."
The full report of Mr Wood’s restoration hearing can be found at www.rcvs.org.uk/disciplinary
The box, which is aimed at both veterinary surgeons and nurses, contains two USB sticks which contain the wound care education sessions, a Bluetooth speaker, product samples, clinical literature, case studies and Time Out wafer bars to enjoy while you learn.
You can also book a timeslot with a representative from Essity to answer any clinical or product related questions raised by the contents of the box.
Richard Barker, Account Sales Executive at Essity said: "Time Out Training allows us to educate vets and vet nurses directly in practices within timescales that we could not previously achieve. We feel this is the future of education in busy veterinary settings, allowing for emergency interruptions, and allowing training of all staff within the convenient setting of their own practice."
Fiona Garrard RVN said: "I found this to be a very easy to follow and very informative webinar. It is full of content that is very useful and aids a good, underpinning knowledge of infections in wounds, and why they happen. It was packed with content and not long-winded or boring at any point."
Time Out Training takes an hour to complete. You can order it for your practice by emailing animalhealthcare@essity.com or dialing 01482 670124.
Novartis Animal Health has launched Onsior®, a coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs.
According to the company, NSAIDs traditionally inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs.
Novartis says tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly.
Dosed once daily, Novartis says Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:
Kelly Doucette, DVM, Global Technical Services Manager with Novartis Animal Health said: "With the benefits of being tissue selective, sparing COX-1, and having a short blood half-life - as well as being approved for both cats and dogs - Onsior will stand out as the new pain reliever of choice for vets."
Folkert Kamphuis, COO Novartis Animal Health added: "Onsior covers multiple indications, works for cats and dogs, comes in two formulations - oral and injectable - and is very simple to dose, which allows veterinarians to use it as the cornerstone of pain management in their clinics. With this complete range, Onsior will offer veterinarians a convenient solution addressing all their different needs."
The Pets at Home Vets Group has joined forces with the National Trust to help raise awareness of pet safety during the summer, for its latest marketing push.
The campaign will see veterinary surgeons and nurses from Vets4Pets and Companion Care practices touring the country hosting 'Out & About' roadshows at National Trust venues across England and Northern Ireland, from July through to September.
Huw Stacey, Head of Clinical services & Veterinary surgeon said: "The summer period presents a number of hazards for pets and we're holding the 'Out & About' roadshow to meet as many pet owners as we can to help raise awareness about how you can help keep pets happy and healthy over the summer. Visitors to the roadshow will have the opportunity to speak face-to-face with vets and nurses from their local Vets4Pets or Companion Care practice.
They'll be providing practical advice on everything from avoiding heat stroke and dehydration, to being aware of poisoning hazards such as wet creosote on garden fences and the dangers associated with taking dogs to the beach such as jellyfish stings and cuts from broken glass. We've teamed up with the National Trust as they have some excellent dog-friendly venues and are a great place for pet owners to get out and about with their dogs over the summer."
Dr Rod Hebden, Head of Corporate Partnerships at the National Trust said: "The National Trust has got hundreds of dog-friendly places to visit in the coast and countryside, and many of our gardens and parks welcome dogs on leads, so we are delighted to be working with Vets4Pets and Companion Care to help our visitors keep their pets healthy and happy this summer. Lots of our 4 million members are pet owners, so our partnership with Britain's largest veterinary group provides them with access to great tips and advice from Vets4Pets animal-loving experts, which is really relevant to our supporters."
The Out & About campaign has a dedicated website www.petslovesummer.co.uk where pet owners can search for their nearest event venue as well as watch short videos with help and advice on how to keep pets safe and healthy throughout the summer.
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
Prevexxion RN is composed of a serotype-1 construct vaccine which Boehringer says offers a unique balance between safety and efficacy against the most virulent types of Marek’s disease virus strains.
Prevexxion RN+HVT+IBD is a solution combining Prevexxion RN and Vaxxitek HVT+IBD in one ampoule. It is designed to meet the needs of customers in long-life bird segments with protection from the hatchery.
Prevexxion RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen.
Jerôme Baudon, Head of Poultry at Boehringer Ingelheim, said: “Our Prevexxion RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection. Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.
Prevexxion RN is the new golden standard for Marek's disease vaccination programs2”.
For more information, contact your Boehringer Ingelheim representative.
Reference
Billed as an essential reference, the new guide gives practical information on pain management in a wide range of small animals, emphasizing patient welfare and evidence-based medicine.
The BSAVA Guide to Pain Management in Small Animal Practice is edited by Ian Self, an RCVS and European Specialist in Veterinary Anaesthesia and Analgesia.
Each chapter is written by a specialist in the field, and the guide includes 'Authors’ perspectives' and case examples.
The first six chapters cover key areas in pain management, including the physiology of pain, acute and chronic pain, and pharmacological and physical treatment of pain. The remaining chapters look at specific types of pain, and pain in species commonly encountered in small animal practice.
Ian said: "This Guide is not to be seen as an instruction manual, rather a helping hand. For each case discussed and analgesic approach explained, there are multiple valid alternative approaches… when seeking inspiration or information when faced with a patient in pain, we hope that the information presented here will assist in reaching a satisfactory clinical outcome."
The new book will be given to eligible vet and vet nurse members free of charge as part of the Association's loyalty scheme; a 'thank you' for staying a member for another year. Further details are available from the member benefits section of the BSAVA website.
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
Kruuse has launched the Buster Premium Dog Collar, described as the greatest innovation in Elizabethan dog collars since the original.
The company says the new collar has been designed with two things in mind. First and foremost, patient comfort. Secondly, ease-of-use. Both should help improve compliance.
The new product uses perforated neoprene to provide a snug fit round the neck with no need to attach a separate collar. It's fastened using Velcro, to give a quick but secure fitting. There's padded banding around the inner edge to provides extra comfort and prevent skin irritation, and additional banding around the outer edge to protect the dog's surroundings.
Andrew Groom, Managing Director at Kruuse said: "Worldwide, the Buster collar is the most trusted device to prevent canine patients from biting or licking their body or scratching their head and neck while wounds or injuries heal. The functionality of an e-collar is outstanding when it comes to postoperative care and prevention of self-inflicted trauma.
"The new Buster Premium Collar has been developed in association with vets, vet nurses and dog owners to provide an exceptional collar that is as stress-free as possible for the patient whilst providing exceptional functionality for the user both at the veterinary hospital and at home."
The Premium Buster Collar is available exclusively via NVS: www.vetwholesaler.co.uk
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.
The company says it recognises how frustrating it can be for veterinary surgeons if the owner doesn't recognise that their dog has a painful condition. This can be compounded by short consult times, leaving vets unable to fully communicate the implications and treatment options for the disease.
In the video, Zoe encourages vets to tailor their language to each case, in particular, using the language dog owners will use.
While undertaking her research Zoe noticed that many owners do not talk about OA in the same way that vets might; instead of referring to lameness or pain, many owners will refer to the actual physical signs of OA such as stiffness or communicate that their dog is slowing down.
Zoe has also warned that not all owners are convinced by visual demonstrations such as flexing and extending the dogs joints. Instead, she suggests encouraging the owner to get hands-on.
Zoe said: "Point out the visual changes suggestive of osteoarthritis that you can see, such as muscle loss, scuffed nails, and enlarged joints. And encourage them to have a look and a feel, comparing affected and unaffected joints. Hopefully, the owner may be more receptive to the conversation now they associate it with a symptom they can recognise."
Zoe says she also finds that many owners of older dogs often misinterpret the signs of OA as 'just old age' and may not be aware that the condition can be managed effectively with medication, the right exercise, diet and by making modifications in the home.
Elanco has also produced an OA management template which enables both the vet and the owner to create a tailored plan. It provides the owner with information to take away with them about how to modify their home, written in collaboration with Founder of Canine Arthritis Management, Hannah Capon.
Lastly, Zoe recommends a whole practice approach to becoming experts on OA, veterinary nurses in particular. She said: "Vet nurses often have great ideas about how to explain the condition in a way that owners understand. Better owner understanding of OA should lead to better adherence to treatment plans and ultimately better clinical outcomes."
To watch the video, click here.
To access the suite of assets Elanco has created for Onsior (which includes the management plan, social media posts for the practice, and infographic to help owners to spot the signs of OA) visit: www.myelanco.co.uk
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
Ceva says the new product is the fruit of research into the composition of the main feline pheromones which pass through the incisive ducts to the Vomeronasal Organ (VNO), which in turn led to the discovery of a new pheromone complex which 'provides an enhanced message of social confidence and safety in the cat’s environment by conveying more impactful messages to it'.
According to the company, Feliway Optimum helps cats with more signs of stress, in more situations and calms cats better than ever. The product is proven to help with more stress-related signs faster than existing pheromones, with all signs of stress showing continuous improvement until day 28 of use and are visible from day 71. These include scratching, urine spraying, multi-cat tensions and conflicts and changes and fears.
Feliway Optimum is available as a plug-in diffuser with 30-day refills.
Abigail King, senior behaviour product manager at Ceva Animal Health said: "We have led the way with research for over 20 years with Feliway Classic and Feliway Friends, but it is now time to go that step further.
"Feliway Optimum is an extremely exciting addition to the range which will help solve all common signs of stress to provide enhanced serenity in a household.
"Nearly 60 per cent of cats show visible signs of stress2 and Feliway Optimum will really help combat this with an over 70% reduction”.
There is a webinar about the new product, presented by Professor Patrick Pageat and Dr Andy Sparkes, which is available by emailing Ceva.
For more information, visit www.feliway.com/uk, call Ceva on 01494 781510 or email cevauk@ceva.com.
References
For the research1, 190 faecal samples were collected from dogs in 140 households (114 samples from raw fed dogs and 76 from non-raw fed dogs).
Salmonella species was detected in 4% of the samples (all raw fed) and antimicrobial-resistant E. coli was detected in 40% of all dogs, but in 62% of raw fed dogs.
The authors say that statistical analysis confirmed that this represented a significantly higher prevalence of AMR E. coli, including multidrug resistance and third generation cephalosporin resistance, and Salmonella species in dogs fed raw compared to non-raw meat diets.
The authors concluded that strategies should be implemented to increase the awareness of the risks of feeding raw meat diets to dogs, to reduce any potential risk to owners, their families, and their pets.
Nicola Di Girolamo, Editor of JSAP says: “In this study, an association between raw meat diets in dogs and faecal carriage of potentially dangerous enteric bacteria has been observed.
"Readers should keep in mind that cross-sectional studies such as this one lay the basis for additional research more suited to prove causality.”
The article looks at the practice, rationale and motivation for raw feeding before evaluating the existing evidence on both the benefits and risks of such diets.
The recent trend away from heat-treated, manufactured pet food for dogs and cats towards raw diets has been driven by suspicion of the former and perceived health benefits of the latter.
However, feeding raw diets, even commercially-prepared ones, does have risks: a recent paper described 13 cats in the UK that appeared to have been infected by Mycobacterium bovis2 by feeding Natural Instinct Wild Venison, a commercial raw mince for cats.
The leader of the investigation, Professor Danièlle Gunn-Moore from the University of Edinburgh said: "Feeding raw food was the only conceivable route of infection in most cases; this outbreak of tuberculosis has now affected more than 90 individuals in over 30 different locations, with more than 50 of the cats developing clinical disease."
One of the authors of the review, Dr Andrew Wales, said: "Formal evidence does exist for claims by raw‐feeding proponents of an altered intestinal microbiome and (subjectively) improved stool quality. However, there is currently neither robust evidence nor identified plausible mechanisms for many of the wide range of other claimed benefits.
"There are documented risks associated with raw feeding, principally malnutrition (inexpert formulation and testing of diets) and infection affecting pets and/or household members. Salmonella has been consistently found and there is also a risk of introducing antimicrobial-resistant bacteria."
The full review article can be found in the June issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here https://onlinelibrary.wiley.com/doi/10.1111/jsap.13000
Canixin L is an inactivated bacterial vaccine used to stimulate active immunity in dogs against two serogroups of Leptospira interrogans: Canicola and Icterohaemorrhagiae.
The new vaccine is licensed to reduce infection, clinical signs, kidney colonisation, renal lesions and shedding in the urine.
Virbac says Canixin L will play a crucial role in minimising the risk of the disease in both the individual and other animals that may come into contact.
It is licensed for use in dogs from 8 weeks of age, with a second injection administered 3 to 4 weeks later.
Virbac says that for the Canicola serogroup, Canixin L offers the highest level of protection, including prevention of mortality.
Rain Beckles – Product Manager, said: “Virbac is pleased to be able to offer Canixin L, allowing those using Canixin DHPPi/L to vaccinate with L2 only in the intermediate years.
“It also provides an excellent opportunity for practices with clients specifically requesting an L2 vaccine.”
https://uk.virbac.com
On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.
On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.
Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.
Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”
Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfonta
For more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta
Merial has launched the latest edition of its Osteoarthritis (OA) Expert series, covering key aspects of management such acute OA flare up.
Produced by Steven J Butterworth MA VetMB CertVR DSAO MRCVS from Weighbridge Referral Centre Swansea, the update advises on key issues, including when surgery might be necessary. Steven is an RCVS Recognised Specialist in Small Animal Surgery (Orthopaedics) and this latest contribution to the guide also looks at patient monitoring and factors such as lifestyle, diet, physiotherapy and the role of NSAIDs.
Previcox product manager Claire Edmunds said: "The quarterly updates are each written by an expert in their field and provide an opportunity for practising vets to update their OA expertise.
"As with every update vets can put their knowledge to the test, and one lucky winner will receive £500 worth of CPD vouchers. Released quarterly, the updates have proved extremely popular. Each paper has a related quiz containing key questions from the discussion and the winner will be the first correct entry drawn at random."
The company will produce further editions next year covering topics including conservative management of canine osteoarthritis and rehabilitation.
If you haven't received a manual and would like a copy, please contact your local Merial territory manager or call the customer hotline on 0870 6000 123.
For the study1, treatment and outcomes of ureter injuries due to ovariohysterectomy complications in cats and dogs was undertaken at the Royal Veterinary College. A retrospective case series of cats and dogs with ureteric injuries resulting from ovariohysterectomy was obtained from patient records at the Queen Mother Hospital for Animals. Fourteen female cats and five female dogs were included in the analysis. Descriptive statistics were used to report presenting clinical signs, clinical pathology, treatment and outcomes.
Professor Vicky Lipscomb, lead author of the paper, said “Presenting clinical signs of ureter injury following neutering in this study were non-specific, such as anorexia, vomiting and lethargy. Importantly, the clinical signs consistently developed immediately or shortly after surgery in the majority of animals. Therefore, the appearance of one or more clinical signs following neutering should raise suspicion of a neutering complication.
"The overall outcome for the 19 animals was excellent in 13 (68%), good in one (5%), fair in one (5%) and poor in four (22%). Ureteroneocystostomy (ureteral re-implantation) is preferred to ureteronephrectomy (removal of kidney and ureter) to preserve renal function and is usually a requirement for bilateral ureteric injuries but carries a high complication rate resulting in additional surgery, albeit often with an excellent final outcome.”
Nick Jeffery, editor of JSAP said: “Ovariohysterectomy is a common surgical procedure in cats and dogs, but the procedure carries a (low) risk of injury to one or both ureters due to the close proximity of the female reproductive tract and the ureters. This research highlights the need for vigilance regarding clinical signs following neutering but demonstrates that surgical treatment of ureteric injuries can have good patient outcome."
The full article can be found in the March issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13100
Photo: Luisa Dormer BSAVA
The programme gives farmers and veterinary surgeons access to new resources, enabling a coordinated and consistent approach to farmer training in the responsible use of antibiotics.
The development of the AMBP Programme has been led by NOAH in partnership with a group of stakeholders from across the industry including farmers, vets, the Responsible Use of Medicines in Agriculture Alliance (RUMA), the Veterinary Medicines Directorate (VMD), the British Retail Consortium (BRC) and leading academics, to create a training programme for all those working in the sheep, dairy, beef and pig sectors.
NOAH says the programme will raise awareness, knowledge and understanding of antimicrobial resistance (AMR) and help drive best practice in a consistent manner across UK farms when it comes to using antibiotics.
Training modules are available for farmers to access via the NOAH website or directly through an online Lantra eLearning platform.
In addition to the direct farmer offering, veterinary surgeons will also be to access resource materials, enabling them to deliver training to their clients. This veterinary resource centre will follow soon.
NOAH Chair, Gaynor Hillier, said: "We know that there is a real demand for this type of accessible training and we’re delighted to be able to lead the way in making it available.
"This new collaborative, cross-sector strategy on training will support both farmers and vets, demonstrating that our farmers have the skills to use antibiotics responsibly, providing reassurance to consumers and policy makers. NOAH is happy to be building on existing antibiotic stewardship achievements within the farming sector as ensuring best practice is vital to safeguard the future efficacy of antibiotics for us all.”
Biosecurity Minister Lord Gardiner said:
"The UK is at the forefront of global efforts to tackle antibiotic resistance. Recent statistics show there has been a 27 per cent drop in use of antibiotics in food-producing animals in the UK since 2014 - meeting a government commitment two years early.
"Our farmers and vets must be commended for driving down antibiotic use in livestock to this all-time low - setting an excellent example for others around the world to follow. But it is vital we continue making progress.
"We welcome this new responsible use of antibiotics farmer training programme, which will support the animal medicines industry to take another positive step towards tackling resistance, safeguarding antibiotics for future generations."
Photo: Lord Trees introduced the launch event and outlined his support for the AMBP programme.